Performance characteristics of a tumor-informed circulating tumor DNA (ctDNA) minimal residual disease (MRD) assay in stage 1-3 colorectal cancer (CRC) in clinical practice

被引：0
|
作者：
Somer, B. [1 ]
Mehler, S. [2 ]
Hasenburg, A. [3 ]
Greene, H. [4 ]
Tauer, K. [4 ]
Grothey, A. [5 ]
机构：
[1] Univ Tennessee, West Canc Ctr, Germantown, TN USA
[2] Technion Israel Inst Technol, Rappaport Fac Med, Haifa, Israel
[3] Charite Univ Med Berlin, Berlin, Germany
[4] West Canc Ctr & Res Inst, Germantown, TN USA
[5] OneOncology, West Canc Ctr, Germantown, TN USA
来源：
ANNALS OF ONCOLOGY | 2022年 / 33卷
关键词：
D O I：
10.1016/j.annonc.2022.04.372
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-283
引用
收藏
页码：S347 / S347
页数：1
相关论文
共 50 条
  • [1] Performance characteristics of a tumor-informed circulating tumor DNA (ctDNA) minimal residual disease (MRD) assay in invasive bladder cancer in clinical practice.
    Mehler, Shoshana
    Guilbeau, Seth
    Somer, Shmuel
    Reed, Kevin
    Greene, Heather
    Vaena, Daniel A.
    Grothey, Axel
    Somer, Brad
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [2] Tumor-Informed Circulating Tumor DNA for Minimal Residual Disease Detection in the Management of Colorectal Cancer
    Emiloju, Oluwadunni E.
    Storandt, Michael
    Zemla, Tyler
    Tran, Nguyen
    Jethwa, Krishan
    Mahipal, Amit
    Mitchell, Jessica
    Thiels, Cornelius
    Mathis, Kellie
    McWilliams, Robert
    Hubbard, Joleen
    Sinicrope, Frank
    Shi, Qian
    Jin, Zhaohui
    [J]. JCO PRECISION ONCOLOGY, 2024, 8
  • [3] A patient-specific, tumor-informed, circulating tumor DNA (ctDNA)-based minimal residual disease (MRD) assay in surgical patients with biliary tract cancer
    Song, Tianqiang
    Wu, Qiang
    Cui, Yunlong
    Li, Huikai
    Zhang, Wei
    Fang, Feng
    Xiong, Qingqing
    [J]. CANCER RESEARCH, 2023, 83 (07)
  • [4] Patient-specific tumor-informed circulating tumor DNA (ctDNA) analysis for molecular residual disease (MRD) detection in surgical patients with stage I-IV colorectal cancer (CRC).
    Cao, Di
    Wang, Fu-Long
    Li, Cong
    Zhang, Rong-Xin
    Wu, Xiao-Jun
    Li, Liren
    Lu, Zhen-Hai
    Pan, Zhi-Zhong
    Lin, Jun-zhong
    Wu, Miaoqing
    Liu, Yifan
    Lv, Guangzhao
    Li, Min
    Wang, Chenyang
    Li, Xi
    Chen, Gong
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 213 - 213
  • [5] A tumor-informed, hybrid-capture based ctDNA assay for minimal residual disease (MRD) detection in colorectal cancer (CRC) patients after curative surgery
    Han, S-W.
    Heo, S.
    Lim, Y.
    Lee, W.
    Kim, H-P.
    Kim, S. Y.
    Bang, D.
    Park, K. J.
    Oh, S. T.
    Yoo, C. S.
    Kang, S-B.
    Kim, Y-J.
    Kim, T-Y.
    [J]. ANNALS OF ONCOLOGY, 2022, 33 (07) : S710 - S711
  • [6] Clinical experience of a personalized and tumor-informed circulating tumor DNA assay for minimal residual disease detection in oligometastatic colorectal cancer patients
    Cohen, S.
    Hook, N.
    Krinshpun, S.
    Westbrook, L.
    Loranger, K.
    Wallace, J.
    Aleshin, A.
    Billings, P.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 : S229 - S229
  • [7] Clinical Applications of Minimal Residual Disease Assessments by Tumor-Informed and Tumor-Uninformed Circulating Tumor DNA in Colorectal Cancer
    Gong, Jun
    Hendifar, Andrew
    Gangi, Alexandra
    Zaghiyan, Karen
    Atkins, Katelyn
    Nasseri, Yosef
    Murrell, Zuri
    Figueiredo, Jane C.
    Salvy, Sarah
    Haile, Robert
    Hitchins, Megan
    [J]. CANCERS, 2021, 13 (18)
  • [8] Enhanced detection of molecular residual disease (MRD) by tumor-informed and tumor-agnostic variants in circulating tumor DNA (ctDNA)
    Yan, Xiaoluan
    Li, Zhencong
    Wang, YanYan
    Li, Juan
    Liu, Ming
    Wang, Hongwei
    Jin, Kemin
    Bao, Quan
    Wang, Lijun
    Liu, Wei
    Liu, Lijuan
    Da, Xu
    Hu, Yifan
    Zhang, Yiqun
    Zang, Yuehua
    Pei, Zhihua
    Wang, Dongliang
    Zhou, Qiming
    Xing, Baocai
    Wang, Kun
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [9] Analytical and clinical validation of a personalized, tumor-informed circulating tumor DNA assay for minimal residual disease detection
    Yang, Zuoquan
    Zhou, Yanqing
    Chen, Yaru
    Teng, Jiaman
    An, Heng
    Cheng, Shaochen
    Xu, Mingyan
    Chen, Shifu
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [10] Finding Waldo: The Evolving Paradigm of Circulating Tumor DNA (ctDNA)-Guided Minimal Residual Disease (MRD) Assessment in Colorectal Cancer (CRC)
    Chakrabarti, Sakti
    Kasi, Anup Kumar
    Parikh, Aparna R.
    Mahipal, Amit
    [J]. CANCERS, 2022, 14 (13)
12345